High response rate to cisplatin/etoposide regimen in childhood low-grade glioma

Journal of Clinical Oncology

Volumn 20, Issue 20, 2002, Pages 4209-4216

  Massimino, Maura ^a   Spreafico, Filippo ^a   Cefalo, Graziella ^a   Riccardi, Riccardo ^a   Tesoro Tess, John David ^a   Gandola, Lorenza ^a   Riva, Daria ^a   Ruggiero, Antonio ^a   Valentini, Laura ^a   Mazza, Elena ^a   Genitori, Lorenzo ^a   Di Rocco, Concezio ^a   Navarria, Piera ^a   Casanova, Michela ^a   Ferrari, Andrea ^a   Luksch, Roberto ^a   Terenziani, Monica ^a   Balestrini, Maria Rosa ^a   Colosimo, Cesare ^a   Fossati Bellani, Franca ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE;

ARTICLE; CANCER GRADING; CLINICAL ARTICLE; DISEASE ACTIVITY; DRUG RESPONSE; FEMALE; FUNCTION TEST; GLIOMA; HUMAN; MALE; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; CISPLATIN; ETOPOSIDE; FEMALE; GLIOMA; HEARING DISORDERS; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; SURVIVAL ANALYSIS;

EID: 0037108821     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.08.087     Document Type: Article

References (48)

1. Packer RJ, Lange B, Ater J, et al: Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 11:850-856, 1993
2. Fisher BJ, Bauman GS, Leighton CE, et al: Low-grade gliomas in children: Tumor volume response to radiation. J Neurosurg 88:969-974, 1998
3. Karim ABM, Maat B, Hatlevoll R, et al: A randomised trial on dose-response in radiation therapy of low-grade cerebral gliomas: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 36:549-556, 1996
4. Gajjar A, Sanford RA, Heideman R, et al: Low-grade astrocytoma: A decade of experience at St. Jude Children's Research Hospital. J Clin Oncol 15:2792-2799, 1997
5. Strojan P, Petric-Grabnar G, Zupancic N, Jereb B: Concomitant chemoradiotherapy for incompletely resected supratentorial low-grade astrocytoma in children: Preliminary report. Med Pediatr Oncol 32:112-116, 1999
6. Packer R, Sutton LN, Bilaniuk LT, et al: Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: An update. Ann Neurol 23:79-85, 1988
7. Petronio J, Edwards SB, Prados M, et al: Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg 74:701-708, 1991
8. Prados MD, Edwards MSB, Rabbitt J, et al: Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol 32:235-241, 1997
9. Castello MA, Schiavetti A, Padula A, et al: Does chemotherapy have a role in low-grade astrocytoma management? A report of 13 cases. Med Pediatr Oncol 25:102-108, 1995
10. Durand RE, Goldie JH: Interaction of etoposide and cisplatin in an in vitro tumor model. Cancer Treat Rep 71:673-679, 1987
11. Kobayashi T, Yoshida J, Ishiyama J, et al: Combination chemotherapy with cisplatin and etoposide for malignant germ-cell tumors: An experimental and clinical study. J Neurosurg 70:676-681, 1989
12. Massimino M, Gandola L, Cefalo G, et al: Management of medulloblastoma and ependymoma in infants: A single-institution long-term retrospective report. Childs Nerv Syst 16:15-20, 2000
13. Massimino M, Gefalo G, Luksch R: CDDP/VPI6 chemotherapy for childhood low-grade gliomas: A mono-institutional study. 8th International Symposium on Pediatric Neuro-Oncology, Rome, Italy, May 6-9, 1998
14. Gnekow AC: Recommendations of the Brain Tumor Subcommittee for the reporting of trials: SIOP Brain Tumor Subcommittee - International Society of Pediatric Oncology. Med Pediatr Oncol 24:104-108, 1995
15. Kaplan E, Meyer P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
16. Lunsford LD, Samaza S, Kondziolka D, Flickinger JC: Survival after stereotactic biopsy and irradiation of cerebral non anaplastic non pilocytic astrocytoma. J Neurosurg 82:523-529, 1995
17. Miralbell R, Blart J, Matias G, Molet J, Ariza A, Craven-Bartle J: Radiotherapy for supratentorial low-grade gliomas: Results and prognostic factors with special focus on tumor volume parameters. Radiother Oncol 27:112-116, 1993
18. Hoffman HJ, Humphreys RP, Drake JM, et al: Optic pathway/hypothalamic gliomas: A dilemma in management. Pediatr Neurosurg 19:186-195, 1993
19. Listernick R, Louis DN, Packer RJ, Gutmann DH: Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the NFl Optic Pathway Glioma Task Force. Ann Neurol 41:143-149, 1997
20. Grill J, Couanet D, Cappelli C, et al: Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann Neurol 45:393-396, 1999
21. Jenkin D, Angyalfi S, Becker L, et al: Optic glioma in children: Surveillance, resection, or irradiation? Int J Radiat Oncol Biol Phys 25:215-225, 1992
22. Bataini JP, Delanian S, Pouvert D: Chiasmal gliomas: Results of irradiation management in 57 patients and review of literature, Int J Radiat Oncol Biol Phys 21:615-623, 1991
23. Gnekow AK, Kaatsch P, Kortmann R, et al: HIT-LGG: Effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood - An interim report. Klin Padiatr 212:177-184, 2000
24. Chan MY, Foong AP, Heisey DEM, et al: Potential prognostic factors of relapse-free survival in childhood optic glioma: A multivariate analysis. Pediatr Neurosurg 29:23-28, 1998
25. Shuper A, Horev G, Kornreich L, et al: Visual pathway glioma: An erratic tumour with therapeutic dilemma. Arch Dis Child 76:259-263, 1997
26. Mahoney DH, Cohen ME, Friedman HS, et al: Carboplatin is effective therapy for young children with progressive optic pathway tumors: A Pediatric Oncology Group phase II study. Neurooncology 2:213-220, 2000
27. Moghrabi A, Friedman HS, Burger PC, et al: Carboplatin treatment of progressive optic pathway gliomas to delay radiotherapy. J Neurosurg 79:223-227, 1993
28. Peters U, Preisler-Adams S, Hebesein A, et al: Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin. Acta Otorinolaringol Esp 51:469-477, 2000
29. Orts Alborch M, Garcia Callejo J. Morant Ventura A, et al: Clinical study on the ototoxicity of cisplatin with distortion products. Anticancer Drugs 11:639-643, 2000
30. Vermorken JB, Kaptein TS, Hart AA, Pinedo HM: Ototoxicity of cisdiaminedichloroplatinum (II): Influence of dose, schedule and mode of administration. Eur J Cancer Clin Oncol 19:53-58, 1983
31. Lokich J, Anderson N: Carboplatin versus cisplatin in solid tumors: An analysis of the literature. Ann Oncol 9:13-21, 1998
32. Go RS, Adjei AA: Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol 17:409-422, 1999
33. Bin P, Boddy AV, English MV, et al: The comparative pharmacokinetics and pharmacodynamics of cisplatin and carboplatin in pediatric patients: A review. Anticancer Res 14:2279-2283, 1994
34. Miser J, Krailo M, Smith M, et al: Secondary leukaemia (SL) or myelodysplastic syndrome (MDS) following therapy for Ewing's sarcoma (ES). Proc Am Soc Clin Oncol 16:1863, 1997 (abstr)
35. Smith MA, Rubinstein L, Auderson JR, et al: Secondary leukemia or myelodisplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol 17:275-281, 1999
36. Stiller CA, Chessells JM, Fitchett M: Neurofibromatosis and childhood leukaemia/lymphoma: A population -based UKCCSG study. Br J Cancer 70:969-972, 1994
37. Felix CA: Secondary leukemias induced by topoisomerasetargeted drugs. Biochim Biophys Acta 1400:233-255, 1998
38. Sutton LN, Molloy PT, Sernyak H, et al: Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery. J Neurosurg 83:583-589, 1995
39. Schmandt SM, Packer RJ, Vezina LG: Spontaneous regression of low-grade astrocytomas in children. Pediatr Neurosurg 32:132-136, 2000
40. Kernan JC, Horgan MA. Piatt JH, D'Agostino A: Spontaneous involution of a diencephalic astrocytoma. Pediatr Neurosurg 29:149-153, 1998
41. Balkhoyor KB, Bernstein M: Involution of diencephalic pilocytic astrocytoma after partial resection. J Neurosurg 93:484-486, 2000
42. Packer RJ, Ater J, Allen J, et al: Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive lowgrade gliomas. J Neurosurg 86:747-754, 1997
43. Rossi LN, Pastorino G, Scotti G, et al: Early diagnosis of optic glioma in children with neurofibromatosis type 1. Childs Nerv Syst 10:426-429, 1994
44. Janss AJ, Grundy R, Cnaan A, et al: Optic pathway and hypothalamic/chiasmatic gliomas in children younger than 5 years with a 6-year follow-up. Cancer 75:1051-1059, 1995
45. Listernick R, Charrow J, Tadanori T, Goldman S: Carboplatin therapy for optic pathway in tumors in children with neurofibromatosis type-1. J Neurooncol 45:185-190, 1999
46. Perilongo G, Carollo C, Salviati L, et al: Diencephalic syndrome and disseminated juvenile pilocytic astrocytomas of the hypothalamicoptic chiasm region. Cancer 80:142-146, 1997
47. Gropman AL, Packer RJ, Nicholson HS, et al: Treatment of diencephalic syndrome with chemotherapy. Cancer 83:166-172, 1998
48. Lee AG, Dutton JJ: A practice pathway for the management of gliomas of the anterior visual pathway: An update and an evidence based approach. Neuroophthalmology 22:139-155, 1999